Login / Signup

Current Update on Transcellular Brain Drug Delivery.

Bhakti PawarNupur VasdevTanisha GuptaMahi MhatreAnand MoreNeelima AnupRakesh Kumar Tekade
Published in: Pharmaceutics (2022)
It is well known that the presence of a blood-brain barrier (BBB) makes drug delivery to the brain more challenging. There are various mechanistic routes through which therapeutic molecules travel and deliver the drug across the BBB. Among all the routes, the transcellular route is widely explored to deliver therapeutics. Advances in nanotechnology have encouraged scientists to develop novel formulations for brain drug delivery. In this article, we have broadly discussed the BBB as a limitation for brain drug delivery and ways to solve it using novel techniques such as nanomedicine, nose-to-brain drug delivery, and peptide as a drug delivery carrier. In addition, the article will help to understand the different factors governing the permeability of the BBB, as well as various formulation-related factors and the body clearance of the drug delivered into the brain.
Keyphrases
  • drug delivery
  • blood brain barrier
  • cerebral ischemia
  • resting state
  • cancer therapy
  • white matter
  • functional connectivity
  • drug release
  • emergency department
  • multiple sclerosis